Windward Bio Group prices IPO of 10.3 million shares at $17 each
Basel-based Windward Bio Group priced its IPO at $17 a share. The shares will trade on the Nasdaq Global Market under the symbol WWB.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Windward Bio Group, based in Basel, Switzerland, said its initial public offering of 10.3 million shares was priced at $17 each, according to Dow Jones Newswires. The company had previously expected to sell the same number of shares at a price between $16 and $18. Its largest stockholders include Novo Holdings and OrbiMed.
Alongside the IPO, Windward sold stock and warrants to Sanofi in a $50 million private placement. The shares will trade on the Nasdaq Global Market under the symbol WWB. In September, the company reported positive interim results from the Phase 2 portion of a trial of WIN378 in asthma, testing twice-yearly dosing.
why it matters
The offering priced near the middle of the expected range, which typically signals solid investor demand without signs of overheating. For the broader market this is a small biotech listing, and the stock's direction will likely depend on further WIN378 data.
tags
instruments
sources
- Windward Bio Group IPO of 10.3M Shrs Prices at $17 Each — Dow Jones Newswires, 12 November 2026 at 23:49 UTC
- Windward Bio Group IPO of 10.3M Shares Prices at $17 Each — Dow Jones Newswires, 13 November 2026 at 00:04 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗